Buy, Sell or Hold: Iovance Biotherapeutics (IOVA-Q)

Home

Daily Stock Opinions and Ratings

Iovance Biotherapeutics (IOVA-Q)

NASDAQ:IOVA

3.17

0.04 (1.28%) 1d

Nervous markets await Nvidia

BUY

A biopharma in the cancer space. Shares are jumping today. The market is buying big upside calls $10 higher than current share prices. They may release good news at one of the upcoming medical conferences.

Showing 1 to 1 of 1 entries

Iovance Biotherapeutics(IOVA-Q) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Iovance Biotherapeutics is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Iovance Biotherapeutics(IOVA-Q) Frequently Asked Questions

What is Iovance Biotherapeutics stock symbol?

Iovance Biotherapeutics is a American stock, trading under the symbol IOVA-Q on the NASDAQ (IOVA). It is usually referred to as NASDAQ:IOVA or IOVA-Q

Is Iovance Biotherapeutics a buy or a sell?

In the last year, there was no coverage of Iovance Biotherapeutics published on Stockchase.

Is Iovance Biotherapeutics a good investment or a top pick?

Iovance Biotherapeutics was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Iovance Biotherapeutics.

Why is Iovance Biotherapeutics stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Iovance Biotherapeutics worth watching?

In the last year, there was no coverage of Iovance Biotherapeutics published on Stockchase.

What is Iovance Biotherapeutics stock price?

On 2025-05-08, Iovance Biotherapeutics (IOVA-Q) stock closed at a price of $3.17.

Most Recent Experts

Daniel Straus

National Bank Financial

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Stan Wong

Private Wealth Management, ScotiaMcleod

Stockchase Insights

5i Research

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.